SHULTZ GEORGE P 4
4 · Accretive Health, Inc. · Filed May 27, 2010
Insider Transaction Report
Form 4
SHULTZ GEORGE P
Director
Transactions
- Sale
Common Stock
2010-05-25$11.28/sh−33,844$381,760→ 677,120 total(indirect: By Trust) - Conversion
Series A Convertible Preferred Stock
2010-05-25−262.86→ 0 total(indirect: By Trust)→ Common Stock (315,828 underlying) - Conversion
Series D Convertible Preferred Stock
2010-05-25−10,800.03→ 0 total(indirect: By Trust)→ Common Stock (42,336 underlying) - Conversion
Common Stock
2010-05-25+358,164→ 710,964 total(indirect: By Trust) - Other
Common Stock
2010-05-25$12.00/sh+11,052$132,624→ 688,172 total(indirect: By Trust)
Footnotes (4)
- [F1]The shares are held in a trust, the beneficiaries of which are Mr. Shultz and his wife.
- [F2]Reflects shares of Common Stock received in satisfaction of a liquidation preference payment required to be paid to the The Shultz 1989 Family Trust upon the closing of the Issuer's initial public offering.
- [F3]The Series A Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1,201.5069 for one basis and had no expiration date.
- [F4]The Series D Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 3.92 for one basis and had no expiration date.